Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Patrícia Bozza and Thiago Souza.
Patrícia Bozza
Connection Strength
1.623
Thiago Souza
  1. In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother. 2021 06 18; 76(7):1874-1885.
    View in: PubMed
    Score: 0.238
  2. Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 May 19; 7(1):116.
    View in: PubMed
    Score: 0.237
  3. Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil. Emerg Infect Dis. 2021 May; 27(5):1446-1453.
    View in: PubMed
    Score: 0.235
  4. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 Mar 01; 7(1):43.
    View in: PubMed
    Score: 0.233
  5. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020 12; 16(12):e1009127.
    View in: PubMed
    Score: 0.230
  6. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Antimicrob Agents Chemother. 2020 09 21; 64(10).
    View in: PubMed
    Score: 0.226
  7. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020 09 10; 136(11):1330-1341.
    View in: PubMed
    Score: 0.226
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.